Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Instil Bio (TIL) Surges on Promising Cancer Therapy Licensing Deal
Summit Therapeutics Secures $235 Million in Funding from Leading Biotech Investors
Monopar Therapeutics’ (MNPR) MNPR-101-Zr Shows Promising Tumor Targeting in Early Clinical…
Relay Therapeutics Shows Promising Results with RLY-2608 in Breast Cancer Study
SINTX Technologies (SINT) Secures Key Patent, Solidifies Leadership in Advanced Ceramics
Finance
Aligos Therapeutics ($ALGS): A Bold Move to Regain Nasdaq Compliance
Portage Biotech Inc. (NASDAQ: PRTG): A Closer Look at a Tumultuous…
Avalon GloboCare (ALBT) surges post Launch of Innovative Male Incontinence Device
Reason why Inspirato Incorporated (ISPO) has high trading volume today
Clearmind Medicine Inc (CMND) briefly surges and here’s why
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
NASDAQ:SGEN
Tag: NASDAQ:SGEN
Seagen Inc. (NASDAQ: SGEN) Enters Licensing Agreement With RemeGen Co Ltd...
Gavins Felicity
-
August 26, 2021
0
Seagen Inc. (NASDAQ:SGEN) Announce Positive CHMP Opinion For TUKYSA For Treating...
Ash K
-
December 31, 2020
0
Seattle Genetics Inc. (NASDAQ:SGEN) Enters Two Oncology Collaboration Agreements With Merck...
Kate Hudson
-
September 24, 2020
0
Seattle Genetics Inc. (NASDAQ:SGEN) Announce Encouraging Results Of TUKYSA Analyses In...
Gavins Felicity
-
June 16, 2020
0
Recent Post
Instil Bio (TIL) Surges on Promising Cancer Therapy Licensing Deal
admin
-
September 12, 2024
0
Biotech company Instil Bio, Inc. (TIL) is experiencing a significant stock price surge today, up 32.51% to $39.29 as of 12:49 PM...
Summit Therapeutics Secures $235 Million in Funding from Leading Biotech Investors
September 12, 2024
Monopar Therapeutics’ (MNPR) MNPR-101-Zr Shows Promising Tumor Targeting in Early Clinical...
September 12, 2024
Relay Therapeutics Shows Promising Results with RLY-2608 in Breast Cancer Study
September 10, 2024
SINTX Technologies (SINT) Secures Key Patent, Solidifies Leadership in Advanced Ceramics
September 10, 2024
